Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The new screenshot shows a rearranged but substantively identical ClinicalTrials.gov Study Details page with all sections present and no new content added or removed. Minor layout adjustments observed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-30T11:32:21.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Updated the page to show revision v3.2.0 and removed v3.0.2.
    Difference
    0.1%
    Check dated 2025-10-01T05:54:50.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content or pricing/availability changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T03:47:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Updated to v3.0.2 from v3.0.1. The Back to Top link has been removed.
    Difference
    0.2%
    Check dated 2025-09-15T19:33:21.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-08T15:05:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page has added a facility name and location, specifically Newcastle upon Tyne, United Kingdom, while also introducing a new version revision (v3.0.0). However, it has removed several related terms and resources that may have provided context about genetic and rare diseases.
    Difference
    3%
    Check dated 2025-09-01T09:43:04.000Z thumbnail image

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.